Great Point Partners LLC Top Holdings and 13F Report (2025) About Great Point Partners LLCInvestment ActivityGreat Point Partners LLC has $418.47 million in total holdings as of September 30, 2025.Great Point Partners LLC owns shares of 43 different stocks, but just 22 companies or ETFs make up 80% of its holdings.Approximately 24.04% of the portfolio was purchased this quarter.About 38.67% of the portfolio was sold this quarter.This quarter, Great Point Partners LLC has purchased 41 new stocks and bought additional shares in 5 stocks.Great Point Partners LLC sold shares of 11 stocks and completely divested from 8 stocks this quarter.Largest Holdings ImmunityBio $28,327,552Vera Therapeutics $26,113,472VOR BIOPHARMA INC $21,501,443Amylyx Pharmaceuticals $20,370,000SAGIMET BIOSCIENCES INC $19,381,606 Largest New Holdings this Quarter 462222100 - Ionis Pharmaceuticals $18,753,000 Holding372303206 - Genmab A/S $18,729,375 Holding07782B104 - Belite Bio $12,736,500 Holding00288U106 - AbCellera Biologics $8,754,000 Holding20451W101 - Compass Pathways $6,220,000 Holding Largest Purchases this Quarter Ionis Pharmaceuticals 420,000 shares (about $18.75M)Genmab A/S 525,000 shares (about $18.73M)Belite Bio 75,000 shares (about $12.74M)AbCellera Biologics 600,000 shares (about $8.75M)Vera Therapeutics 207,881 shares (about $6.71M) Largest Sales this Quarter ABIVAX SA 449,314 shares (about $44.49M)ORUKA THERAPEUTICS INC 158,681 shares (about $13.22M)VOR BIOPHARMA INC 573,090 shares (about $10.93M)CONTINEUM THERAPEUTICS INC 435,298 shares (about $5.84M)OPUS GENETICS INC 1,193,306 shares (about $5.78M) Sector Allocation Over TimeMap of 500 Largest Holdings ofGreat Point Partners LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorIBRXImmunityBio$28,327,5520.0%3,000,8006.8%HealthcareVERAVera Therapeutics$26,113,472$6,712,478 ▲34.6%808,7176.2%HealthcareVOR BIOPHARMA INC$21,501,443$10,934,557 ▼-33.7%1,126,9105.1%COM NEWAMLXAmylyx Pharmaceuticals$20,370,0000.0%700,0004.9%HealthcareSAGIMET BIOSCIENCES INC$19,381,606$674,132 ▼-3.4%1,961,7014.6%COM SER ADEFINIUM THERAPEUTICS INC$19,362,454$3,186,954 ▲19.7%508,7354.6%COM SHSIONSIonis Pharmaceuticals$18,753,000$18,753,000 ▲New Holding420,0004.5%HealthcareGMABGenmab A/S$18,729,375$18,729,375 ▲New Holding525,0004.5%HealthcareSOL-GEL TECHNOLOGIES LTD$17,764,731$2,614,953 ▼-12.8%239,1594.2%SHS NEWZURAZura Bio$16,961,385$576,884 ▼-3.3%4,077,2564.1%HealthcareLB PHARMACEUTICALS INC$15,751,920$3,576,978 ▲29.4%410,4203.8%COM SHSABIVAX SA$15,348,100$44,491,072 ▼-74.4%155,0003.7%SPONSORED ADSANNXAnnexon$15,216,579$411,579 ▲2.8%3,597,3003.6%HealthcareBLTEBelite Bio$12,736,500$12,736,500 ▲New Holding75,0003.0%HealthcareEUPRAXIA PHARMACEUTICALS INC$10,920,0000.0%1,200,0002.6%COMNEKTAR THERAPEUTICS$10,595,3750.0%175,0002.5%COM NEWMLTXMoonLake Immunotherapeutics$10,013,0120.0%855,8132.4%HealthcareELYMEliem Therapeutics$9,176,000$2,294,000 ▼-20.0%800,0002.2%HealthcareABCLAbCellera Biologics$8,754,000$8,754,000 ▲New Holding600,0002.1%HealthcareNEUROGENE INC$8,346,000$1,451,648 ▼-14.8%300,0002.0%COMCONTINEUM THERAPEUTICS INC$6,524,576$5,841,699 ▼-47.2%486,1831.6%CL ACMPSCompass Pathways$6,220,000$6,220,000 ▲New Holding500,0001.5%HealthcareJATT II ACQUISITION CORP$5,622,5000.0%500,0001.3%ORD SHSIFRXInflaRx$5,483,8030.0%3,046,5571.3%HealthcareRESEARCH ALLIANCE CORP III$5,467,970$5,467,970 ▲New Holding504,8911.3%ORD SHS CL ABRIGHT MINDS BIOSCIENCES INC$5,460,4210.0%109,6031.3%COM NEWAMANAT ACQUISITION CORP$5,340,0000.0%500,0001.3%CL A ORDALTAltimmune$4,979,9240.0%1,741,2321.2%HealthcareJATT III ACQUISITION CORP$4,959,000$4,959,000 ▲New Holding450,0001.2%ORD SHSPHVSPharvaris$4,758,000$4,758,000 ▲New Holding150,0001.1%HealthcareSCYNEXIS INC$4,664,8020.0%944,2921.1%COMCGEMCullinan Therapeutics$4,605,0000.0%300,0001.1%HealthcareCYBIN INC$3,944,500$3,944,500 ▲New Holding320,9520.9%COM NEWRZLTRezolute$3,940,4890.0%951,8090.9%HealthcareOPUS GENETICS INC$3,760,104$5,775,601 ▼-60.6%776,8810.9%COMELVNEnliven Therapeutics$3,208,8000.0%70,0000.8%HealthcareRLMDRelmada Therapeutics$3,174,7400.0%842,1060.8%HealthcareDBV TECHNOLOGIES S A$2,940,000$1,094,785 ▲59.3%250,0000.7%SPONSORED ADSEVOMMUNE INC$2,684,5000.0%325,0000.6%COM SHSORUKA THERAPEUTICS INC$2,053,015$13,216,539 ▼-86.6%24,6490.5%COMHUMAHumacyte$1,941,3750.0%3,750,0000.5%HealthcareREIN THERAPEUTICS INC$1,337,168$733,132 ▼-35.4%1,663,1440.3%COM NEWRESEARCH ALLIANCE CORP IV$1,276,752$1,276,752 ▲New Holding106,3960.3%CL A ORD SHSALUMIS INC$0$24,089,557 ▼-100.0%00.0%COMRAREUltragenyx Pharmaceutical$0$20,034,000 ▼-100.0%00.0%HealthcareIMMXImmix Biopharma$0$13,172,489 ▼-100.0%00.0%HealthcareSLNSilence Therapeutics$0$4,941,000 ▼-100.0%00.0%HealthcarePALISADE BIO INC$0$4,775,272 ▼-100.0%00.0%COMGALTGalectin Therapeutics$0$3,712,000 ▼-100.0%00.0%HealthcareAVXLAnavex Life Sciences$0$1,350,167 ▼-100.0%00.0%HealthcarePROMIS NEUROSCIENCES INC$0$1,133,734 ▼-100.0%00.0%COM SHSShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.